Investing.com - Gilead reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $1.82 on revenue of $5.69B. Analysts polled by Investing.com anticipated EPS of $1.72 on revenue of $5.53B. That compared to EPS of $1.91 on revenue of $5.65B in the same period a year earlier. The company had reported EPS of $1.76 on revenue of $5.28B in the previous quarter.
Gilead shares gained 1.57% to trade at $68.14 in after-hours trade following the report.
Gilead follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Pfizer earnings beat analysts' expectations on Monday, with second quarter EPS of $0.8 on revenue of $13.26B. Investing.com analysts expected EPS of $0.75 on revenue of $13.41B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar